Stephen is one of the founders of The George Institute for Global Health, an architect of its global expansion and currently holds the position of Principal Director of The George Institute for Global Health (worldwide).

He also holds professorial appointments in medicine at UNSW Sydney and the University of Oxford (UK), where he is a Oxford Martin Senior Fellow. Stephen is an international authority on the causes, prevention and treatment of cardiovascular diseases and has a special interest is the management of chronic and complex conditions in resource-poor settings, particularly in the Asia-Pacific region.

In addition to his Institute and university appointments, Stephen has held several external appointments, including former Chair of the International Scientific Board of the UK BioBank. He is also Executive Chair of George Clinical Pty Ltd, a wholly owned subsidiary of The George Institute. He sits on the Boards of several other not-for-profit organisations, including the Oxford Health Alliance. 

Stephen has published more than 300 scientific papers and delivered more than 200 invited lectures. For his work in the field of cardiovascular disease, he has received numerous awards, fellowships and honours from various governments, universities and learned societies.

Anushka is a Professor of Medicine, UNSW Sydney and a cardiologist at Royal Prince Alfred Hospital in Sydney, Australia. She undertook her medical training at the University of Queensland, with subsequent postgraduate research degrees from Harvard University and the University of Sydney.

As the Chief Scientist of the George Institute for Global Health, she has a key role in developing and supporting global strategic initiatives across the organisation. Her personal research interests focus on developing innovative solutions for delivering affordable and effective cardiovascular care in the community and in acute care hospital settings.

Anushka currently leads research projects relating to these interests in Australia, China and India. She is supported by a Senior Research Fellowship from the Australian National Health and Medical Research Council (NHMRC).

Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia.  He is Executive Director of The George Institute China at Peking University Health Science Center in Beijing, China.

Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia.  He is a past President of the Asia Pacific Stroke Organisation and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group.  He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.

Terry is a non-communicable disease epidemiologist with extensive experience in the conduct of cohort and case control studies. He was previously Director of the Murdoch Children’s Research Institute at the Royal Children’s Hospital, Melbourne, coordinating research projects including those on cancer, heart disease, multiple sclerosis, childhood asthma, and diabetes.

His work has focussed on infant and child health. His team's research on Sudden Infant Death Syndrome and sleeping position was recognised by the NHMRC, Australia, as one of the most important contributions to medical research by Australia in the 20th Century. Much of this work was conducted on the 11,000 infants enrolled in the Tasmanian Infant Health Survey (TIHS) between 1988 and 1995 and was supported by funds from both NH&MRC and NIH.

He is currently playing a leading role in two large global cohort collaborations. The first involves a collaboration of birth cohorts in more than ten countries to obtain prospective evidence on the causes of childhood cancer. Little prospective data on this association has previously been available. This consortium, the International Childhood Cancer Cohort Consortium (14C), seeks to assemble data on approximately 1 million mothers and babies who will be followed through childhood. It has been supported financially by NCI, and currently Terry is working on this from IARC.

The second study is focused on following around 40,000 subjects who were first measured at school age and are now moving into their fourth and fifth decades. The CDAH study is one of six coborts in three countries contributing data to this consortium. This study seeks to estimate the separate effect of childhood physical and lifestyle characteristics on risk of major adult diseases such as type 2 diabetes and cardiovascular disease. There have been many publications on this including one in the New England Journal of Medicine in 2011.

In his work Terry has developed skills in the development of environmental and lifestyle measures, in genetic measures, and the analysis of gene-environment interactions, particularly in the setting of cohort studies, including those set in early life.

Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia.

After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.  

Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium.  Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.

Christine Jenkins is Head of the Respiratory Group at The George institute for Global Health; Senior Staff Specialist in Thoracic Medicine at Concord Hospital, Sydney; Clinical Professor and Head of Respiratory Discipline at University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney.

Christine has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease. She has had major roles in advocacy and leadership for lung health in Australia, chairing the National Asthma Campaign, the Federal Government’s National Asthma Advisory Group and many local and international guidelines and implementation initiatives to enhance resources, skills, capacity and clinical outcomes in airways disease. She was president of the Thoracic Society of Australia and New Zealand from 2007 - 2009.

Christine is an active clinician, and teaches and supervises medical students, advanced trainees and post graduate students. Her area of research interest is the clinical management of airways disease and patient reported outcomes in response to therapeutic interventions, and she is currently implementing trials in asthma and COPD management and pulmonary rehabilitation in Australia and Asia. Christine has written two books on asthma, one for medical students and one for patients, their families and carers. In 2002 she was made a Member in the Order of Australia for recognition of service to respiratory medicine as a physician, administrator and educator, especially in the field of asthma education.

She is on the Board of the Lung Foundation Australia, and is a member of the Thoracic Society of Australia and New Zealand, the American Thoracic Society, European Respirator Society and the Asia-Pacific Society of Respirology.

Erika has over 20 years Human Resources experience in Australia, USA, Europe and Asia. Experienced in all facets of HR leadership, with a particular emphasis on change management and communications/engagement.

Prior organisations include AMP, Citigroup and Colgate-Palmolive.

John Chalmers has an outstanding record in hypertension research, both fundamental and clinical. His groundbreaking research on the role of the brain in the development of hypertension led to his election to Fellowship of the Australian Academy of Science and helped establish Flinders University as a leading international centre in hypertension and neuroscience research.

His studies on the treatment of high blood pressure for the prevention of heart attack and stroke have changed the way patients are treated throughout the world. His work has been recognised through many awards including the Wellcome Medal, the RT Hall Prize of the Cardiac Society of Australia and New Zealand, The Zanchetti Lifetime Achievement Award of the European Society of Hypertension and the Volhard Medal of the International Society of Hypertension.

He has been President or Chairman of the Australian Society of Medical Research, The Royal Australasian College of Physicians, the National Health and Medical research Council of Australia, the WHO Expert Committee on Hypertension, the International Society of Hypertension and the Scientific Advisory Board of the World Heart Federation.

Professor Chalmers' contribution to medical science has been acknowledged through the award of many Honorary Doctoral degrees and extensive appointments on national and international boards and advisory committees. He was appointed a Companion in the Order of Australia (AC) in 1991 and an Officer in the National Order of Merit of France in 2010.

John Chalmers remains an active researcher at The George Institute Australia, where he is a principal investigator on many research grants and Chair of steering committees for major studies, mentors young clinical researchers from around the world, and continues to publish and lecture prolifically. 

Professor John A Myburgh AO, is Professor of Intensive Care Medicine, University of New South Wales; Director of the Division of Critical Care and Trauma at the George Institute for International Health and Senior Intensive Care Physician at the St George Hospital, Sydney.

He holds honorary Professorial appointments at the University of Sydney and Monash University School of Public Health and Preventive Medicine.

He has an extensive research track record over 25 years and is regarded as a national and international expert in catecholamine neurophysiology and pharmacology, trials of clinical management of traumatic brain injury, fluid resuscitation and in the development and co-ordination of over 35 clinical trials in Intensive Care Medicine.

His list of publications and success in recurrent grant funding is in the top 1% of Intensive Care physicians in Australia and within the top 5% internationally. These include over 250 refereed research publications, (including 9 papers in the New England Journal of Medicine) and 45 book chapters and monographs. He holds a Practitioner Fellowship and has received over $42M grant funding from the National Health and Medical Research Council. In addition to other national international grants, total cumulative research funding to the present is over A$70M. He has delivered over 400 presentations at national and international scientific meetings since 1994, including over 50 plenary presentations at major scientific congresses.

He is a Foundation Member and Past-Chairman of the Australian and New Zealand Intensive Care Society Clinical Trials Group. He was instrumental in the establishment of the Australian and New Zealand Intensive Care Research Centre at the Monash University School of Public Health and Preventive Medicine. 

In 2006, he was appointed to establish the Division of Critical Care and Trauma at the George Institute for Global Health and has developed programs of research including new opportunities for clinician-researchers.

In addition to his research profile, he has made a substantive contribution to education in Intensive Care Medicine, both at undergraduate and postgraduate levels over the last 25 years. He was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the first elected President from 2010-2012.

He is a current Council Member for the World Federation of Societies of Intensive and Critical Care Medicine and Fellow of the Australian Academy of Health and Medical Science.

In the 2014 Queen’s Birthday honours, he was made an Officer of the Order of Australia (AO) for distinguished service to medicine as an intensive care medical practitioner, educator and researcher, and as an international innovator in patient management.

Kazem Rahimi is the James Martin Senior Fellow in Essential Healthcare at the University of Oxford and Honorary Consultant Cardiologist at the John Radcliffe Hospital, Oxford. As the Deputy Director of The George Institute UK he leads the Essential Healthcare Programme, which aims to find practical and affordable solutions for the global health priorities of the world’s largest emerging economies, as well as the priorities of vulnerable or disadvantaged populations in established economies.

He graduated in medicine from the University of Leipzig in Germany with postgraduate training in cardiology and health services research in Leipzig, London and Oxford. Prior to joining the George Institute, in 2010, he was a Research Fellow at Oxford’s Clinical Trial Service and Epidemiological Studies Unit. His research interests include service delivery innovation in chronic disease prevention and management, large-scale complex intervention studies, and data-driven electronic decision support systems.

Lily joined the George Institute China in August 2012 as the Head of Finance and Administration and oversees of Finance, Administration and IT. She has solid business capacity and extensive financial management experience, familiar with China GAAP, US GAAP and IFRS.

Her specialties are internal controls and corporate governance and she has previously held senior financial management roles in commercial companies and international charities.

Maree is the Acting Director of the Neurological and Mental Health Division at The George Institute for Global Health.

She leads a program of research focusing on developing simple, cost effective strategies (which can be integrated with other secondary prevention strategies) to identify, treat and prevent depression and significantly improve the outcome for people with cardiovascular disease. Maree has a particular interest in Aboriginal and Torres Strait Islander health and also holds a National Heart Foundation Future Leader Fellowship (Level 2) on Improving the identification and management of depression in people with cardiovascular disease. Maree works one day a week as a Professor of Epidemiology in the Faculty of Health and Wellbeing at The University of Central Lancashire in the United Kingdom.

Dr Parisa Glass is the Director of Operations for the George Institute Australia. In this role she is responsible for directing and enhancing the operational processes for The George Institute Australia.

Parisa is also the Deputy Director with the Critical Care and Trauma Division of The George Institute. In her capacity as Deputy Director, she leads the operations of the Critical Care and Trauma Division and contributes to the academic activity and student supervision.

Parisa has a PhD in Biomedical Science and a Masters Degree in Business Administration. Parisa holds a Senior Lecturer position with UNSW Sydney.

Parisa joined The George Institute in 2008. She has over fifteen years experience in health and university sectors in an operational and academic capacity. Her expertise is in operational management including finance, personnel, contracts, business negotiations, project and program management.

After graduation from Public Health School, Hebei Medical University in 1992, Puhong started his career as teacher and researcher in the same university.

In 2004, he got his doctoral degree from Fuwai Hospital, majored in cardiovascular disease intervention and health economic evaluation. From 2004 to 2011, he worked as the vice director of the Institute of Chronic and Non-communicable Disease Prevention and Control in Beijing CDC, director of Quality Control Department of Beijing Management Centre for Community Health Service, and as the chief officer of the National Action on Healthy Lifestyle for All program in China CDC.

To deal with the rapidly increasing diabetes problem in China, he joined The George Institute, China in May 2011 and currently works as the associate director of GI China and director of CCmHI. 

Richard Mills joins the George Institute from the World Bank, where he was most recently Director of Corporate Communications. There he helped lead efforts to tell the story of a World Bank that more than doubled its support to developing countries during the financial crisis while becoming more focused on openness, results and accountability. He spearheaded the use of new and creative tools across social media, marketing and outreach.

A spokesman for some of the highest profile parts of the United States government, from Congress to the Executive Office of the President to the State Department, Mr Mills has 20 years of experience with international issues in over 60 countries, from trade, economics, conflict and, most recently, poverty and development.